A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Lunesta





FDA calls for lower first dose of Lunesta for sleep - USA Today

9/10/2014
02:19 | Author: Cole Thomas

Lunesta
FDA calls for lower first dose of Lunesta for sleep - USA Today

FDA calls for lowering the first doses of Lunesta to avoid problems from sleep impairment in mornings.

A link has been posted to your Facebook feed.

Patients are often unaware that they are still drowsy. The Food and Drug Administration is taking action based on a study that found Lunesta at recommended doses can cause problems with driving, memory and coordination up to 11 hours after the drug is taken.

To find out more about Facebook commenting please read the Conversation Guidelines and FAQs.

FDA calls for lowering the first doses of Lunesta to avoid problems from sleep impairment in mornings.

WASHINGTON (AP) — U.S. health officials say the maker of Lunesta must lower the starting dose of its sleeping aid drug due to risks of morning drowsiness, which can interfere with driving ability and lead to injury.

A link has been sent to your friend's address.

Settings Cancel Set.

(Photo: JB Reed Bloomberg News via Getty). Lunesta manufacturer Sunovion Pharmaceuticals will lower the starting dose of the tablet.

Drowsiness is a side effect for all anti-insomnia drugs.

Let friends in your social network know what you are reading about.

Patients can increase the dose, but should remember that higher doses are more likely to cause impairment the next day, according to the FDA. Lunesta manufacturer Sunovion Pharmaceuticals will lower the starting dose of the tablet to 1 milligram from 2 milligrams.

You are logged in as Get the news Loading Your News.

Comments (0)



Lunesta - definition of Lunesta by Medical dictionary

7/9/2014
04:02 | Author: Caitlin White

Lunesta
Lunesta - definition of Lunesta by Medical dictionary

Lunesta. Pharmacologic class: Nonbenzodiazepine. Therapeutic class: Hypnotic. Controlled substance schedule IV. Pregnancy risk category C.

GI: nausea, vomiting, diarrhea, dyspepsia, cholelithiasis, dry mouth.

CYP3A4 inducers (such as rifampin): decreased eszopiclone blood level.

Dosage may be increased to 2 mg if indicated clinically. Elderly adults: 1 mg P.O. If patient's chief complaint is difficulty staying asleep, recommended dosage is 2 mg P.O. immediay before bedtime. immediay before bedtime.

⊘ Indications and dosages ➣ Insomnia.

• Hepatic impairment • Concomitant use of other CNS depressants None.

Pregnancy risk category C.

• Don't give with or immediay after a heavy, high-fat meal because this may slow drug absorption and reduce efficacy.

• Before starting therapy, evaluate patient to help eliminate physical or psychiatric causes of insomnia.

Comments (2)Read more